Skip to content

Insider · CIK 0001194247

Paul J Diaz

ceopresidentofficerdirector

Files at MYGN (MYRIAD GENETICS INC). First filing Oct 11, 2024, latest Oct 11, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $344k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

MYGN: MYRIAD GENETICS INC

MYGNOct 9, 2026 · close 4.31

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
20Weak
MYGNsell10b5-1
MYRIAD GENETICS INC
$344k
15,000 shares
-2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 22, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-19,859$10.01$199k989,665Mar 25, 2025
Mar 22, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-52,682$10.01$527k936,983Mar 25, 2025
Mar 24, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-18,312$9.98$183k918,671Mar 25, 2025
Mar 24, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-26,827$9.98$268k891,844Mar 25, 2025
Mar 14, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-37,564$10.07$378k1,039,642Mar 17, 2025
Mar 15, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-30,118$10.07$303k1,009,524Mar 17, 2025
Feb 7, 2025MYGN
MYRIAD GENETICS INC
AGrant or award
Common Stock
+114,828$0.00$01,077,206Mar 4, 2025
Oct 11, 2024MYGN
MYRIAD GENETICS INC
SOpen-market sale
Common Stock10b5-1
-15,000$22.93$344k962,378Oct 11, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Paul J Diaz: insider trades and track record | InsiderTell